Dr
Hannah
Evans

Patent Attorney

Manchester Office

Engineering

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Hannah has a first-class MPhys degree from the University of Oxford and a PhD in High Energy Physics from the University of Cambridge. Hannah’s studies give her a broad understanding of physics, as well as specialist knowledge in the areas of theoretical and particles physics, and the acceleration and detection of atomic and subatomic particles.

Since joining HGF in 2017, Hannah has gained experience in the drafting and prosecution of patent applications for domestic and non-UK clients covering a wide range of subject matter across the fields of engineering and physics. Hannah qualified as a Chartered (UK) Patent Attorney and a European Patent Attorney in 2021.

Qualifications

Patent Attorney

Chartered (UK)
European


MPHYS

Masters in Physics

PHD

PhD in High Energy Physics

POSTGRADUATE DIPLOMA OR CERTIFICATE

PG Cert Intellectual Property

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.